Tag Archives: Others

Policy Analysis and Guidance: Guizhou’s Notification on Guiding and Regulating Private Hospital Development

Guizhou Province’s Health Commission, Medical Insurance Bureau, and Traditional Chinese Medicine Bureau have issued a notification to further guide and regulate the development of private hospitals. This policy aims to promote the healthy, standardized development of private hospitals, enhance medical service quality, and meet the diverse health needs of the public.

Key Policy Highlights

Strengthening Party Leadership
- Organizational Coverage: Expand party organization coverage in private hospitals, establishing separate or joint party organizations based on the number of formal party members.
- Political Core Role: Play the role of party organizations as a political core, ensuring the implementation of party policies and promoting high-quality development through strengthened ideological, cultural, and anti-corruption work.
Regulating Practice Behavior
- Name Standardization: Prohibition misleading names and reserve certain titles exclusive for public healthcare institutions.
- Approval and Verification: Improve approval efficiency and encourage participation in hospital grading evaluations.
- Department Setup: Align department setup with practice scopes and qualifications, prohibiting misleading or unconventional department names.
- Personnel Qualifications: Ensure all medical staff are properly qualified and registered, with a focus on building a structured talent pool.
Enhancing Service Quality
- Quality and Safety Management: Integrate private hospitals into the medical quality management system and establish real-time supervision mechanisms.
- Clinical Technology Application: Standardize the management of medical technologies and surgeries through established directories and dynamic assessments.
- Pharmaceutical and Device Management: Ensure the safety and quality of药品and medical devices, with strict management of high-risk items and traditional Chinese medicine.
- Infection Control: Strengthen hospital infection management through comprehensive systems and staff training.
Supporting Healthy Development
- Specialized Development Guidance: Encourage private hospitals to focus on specialized fields and innovative service models.
- Talent and Specialized Development Support: Provide equal opportunities for private hospital professionals in title evaluations and training.
- Medical Alliance Participation: Support private hospitals in joining medical alliances to promote resource sharing and coordinated development.
- Medical Insurance Policy Support: Facilitate private hospitals’ participation in drug and device procurement and medical insurance services.
Comprehensive Regulation
- Risk Prevention: Establish comprehensive risk management systems to enhance medical safety.
- Regulatory Enforcement: Use various inspection methods to ensure compliance with medical practice and safety standards.
- Information Transparency: Enhance Hospital Information Disclosure Systems to Ensure Accuracy and Prevent Misleading Promotion.
- Credit Evaluation: Implement a credit evaluation system for private hospitals to promote trust and regulatory efficiency.

Policy Orientation and Industry Implications
Guizhou’s policy on guiding and regulating private hospitals reflects a strategic focus on:

Quality Enhancement: Improving medical service quality through rigorous standards and management.
Regulatory Efficiency: Strengthening oversight to ensure compliance and patient safety.
Industry Support: Promoting sustainable growth and innovation in the private hospital sector.

Conclusion
Guizhou’s comprehensive approach to private hospital regulation and support sets a benchmark for regional healthcare management, emphasizing quality, compliance, and industry development. Private hospitals should align with these guidelines to enhance service quality, build public trust, and achieve sustainable growth.-China Health Reform Pulse

Policy Source: https://wjw.guizhou.gov.cn/zwgk/gzhgfxwjsjk/gfxwjsjk/202504/t20250401_87326150.html

Policy Analysis and Guidance: Sichuan’s Medical Device Export Sales Certification Announcement

Sichuan Provincial Drug Administration has released the Medical Device Export Sales Certification Information Announcement (Issue 9, 2025). This initiative aims to provide transparent and accurate information on medical device exports, supporting international market access and enhancing the global competitiveness of domestic medical device enterprises.

Key Policy Highlights

Certification Information Disclosure
- Purpose: To provide the public and international markets with accurate information on certified medical devices.
- Details: The announcement includes detailed certification information for multiple medical device companies, such as Sichuan Bomestar Dental Equipment Co., Ltd.
Regulatory Compliance
- Standards: Ensuring all exported medical devices comply with national standards and regulations.
- Transparency: Making certification information publicly available to enhance trust and facilitate international trade.
International Market Support
- Development: Supporting the international expansion of the medical device industry through clear and efficient certification processes.
- Efficiency: Streamlining the certification process to reduce administrative burdens and promote industry growth.

Policy Orientation and Industry Implications
The export sales certification policy reflects Sichuan’s strategic focus on:

Transparency: Ensuring public and international access to accurate certification information.
Compliance: Strengthening regulatory frameworks to ensure product safety and quality.
Global Competitiveness: Supporting the international development of the medical device sector.

Conclusion
Sichuan’s approach to medical device export sales certification sets a benchmark for regional medical device regulation, emphasizing transparency, compliance, and global competitiveness. Medical device enterprises should align with these guidelines to ensure smooth international operations and build global trust.-China Health Reform Pulse

Policy Source: http://yjj.sc.gov.cn/scyjj/c103180/2025/3/31/8af3a8ea68e1418e93cbeb6915ed4ce7.shtml

Policy Analysis and Guidance: Sichuan’s Class II Medical Device Registration Information Disclosure

Sichuan Provincial Drug Administration has released the registration information disclosure for Class II medical devices from March 24 to 28, 2025. This initiative aims to enhance transparency, ensure public access to accurate registration information, and support the healthy development of the medical device industry.

Key Policy Highlights

Registration Information Disclosure
- Purpose: To provide the public with accurate and timely information about Class II medical device registrations.
- Details: The disclosure includes detailed registration information for multiple medical device companies, such as Chengdu Aikesilun Medical Technology Co., Ltd. and Maccura Biological Co., Ltd.
Regulatory Compliance
- Standards: Ensuring all registered medical devices comply with national standards and regulations.
- Transparency: Making registration information publicly available to enhance trust and facilitate industry supervision.
Industry Support
- Development: Supporting the innovation and development of the medical device industry through clear and efficient regulatory processes.
- Efficiency: Streamlining the registration process to reduce administrative burdens and promote industry growth.

Policy Orientation and Industry Implications
The registration information disclosure policy reflects Sichuan’s strategic focus on:

Transparency: Ensuring public access to accurate and timely registration information.
Compliance: Strengthening regulatory frameworks to ensure product safety and quality.
Industry Growth: Supporting the innovation and sustainable development of the medical device sector.

Conclusion
Sichuan’s approach to Class II medical device registration information disclosure sets a benchmark for regional medical device regulation, emphasizing transparency, compliance, and industry support. Medical device enterprises should align with these guidelines to ensure smooth operations and build public trust.-China Health Reform Pulse

Policy Source: http://yjj.sc.gov.cn/scyjj/c103181/2025/3/31/048eeedf0f8b493f88e66ba834eff0c3.shtml